Pyxis Oncology (PYXS) Enterprise Value: 90.57M

Pyxis Oncology, Inc. (PYXS)

1.64 -0.05 (-2.96%) USD | NASDAQ | Nov 03, 15:15

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2021. Start Trial.

Date	Value
November 02, 2026	90.57M
October 30, 2026	98.18M
October 29, 2026	103.26M
October 28, 2026	108.97M
October 27, 2026	100.08M
October 26, 2026	90.57M
October 23, 2026	89.93M
October 22, 2026	91.84M
October 21, 2026	95.01M
October 20, 2026	100.08M
October 19, 2026	95.01M
October 16, 2026	89.93M
October 15, 2026	97.55M
October 14, 2026	96.91M
October 13, 2026	100.72M
October 12, 2026	110.87M
October 09, 2026	112.14M
October 08, 2026	109.60M
October 07, 2026	110.87M
October 06, 2026	111.50M
October 05, 2026	125.46M
October 02, 2026	119.11M
October 01, 2026	122.29M
September 30, 2026	131.17M
September 29, 2026	167.33M

Date	Value
September 28, 2026	167.33M
September 25, 2026	164.79M
September 24, 2026	168.59M
September 23, 2026	187.62M
September 22, 2026	196.19M
September 21, 2026	185.72M
September 18, 2026	194.60M
September 17, 2026	199.68M
September 16, 2026	195.24M
September 15, 2026	194.60M
September 14, 2026	200.95M
September 11, 2026	186.99M
September 10, 2026	190.80M
September 09, 2026	197.77M
September 08, 2026	230.13M
September 04, 2026	230.13M
September 03, 2026	209.51M
September 02, 2026	221.24M
September 01, 2026	201.58M
August 31, 2026	188.89M
August 28, 2026	188.26M
August 27, 2026	193.97M
August 26, 2026	195.24M
August 25, 2026	177.47M
August 24, 2026	171.13M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks